Antibiotic susceptibility testing of 70 pediatric Helicobacter pylori isolates was performed by using screening agar and disk diffusion methods. Resistance to metronidazole and tinidazole was 72 to 79% and 71 to 81% by modified disk diffusion and 77% and 78% by screening agar, respectively. Susceptibilities to amoxicillin, ampicillin, clarithromycin, tetracycline, erythromycin, and ciprofloxacin were 58, 69, 75, 68, 68, and 65%, respectively.
Resistance to antibiotics among Helicobacter pylori isolates is prevalent worldwide. The rate of metronidazole resistance is on the rise, and it varies according to the population studied. Resistance to amoxicillin and tetracycline has also been observed, and there are reports of high rates of resistance to clarithromycin (1-2, 4, 8-11, 16) . Most antibiotic resistance studies have been done on H. pylori isolates from adults; fewer data are available for children, particularly those in developing countries. The purpose of this study was to assess the susceptibility of pediatric H. pylori isolates to commonly used antibiotics, by using the modified disk diffusion method (MDDM) and the screening agar method (SAM).
During 1997 to 2000, biopsies from 250 children (median age, 9.4 years; range, 3 to 15 years) experiencing recurrent abdominal pain, nausea, and vomiting were used for bacterial culturing. Biopsies were placed within a modified Campy-Thio medium, composed of thioglycolate base medium (Difco), 10% sheep blood (SB), 8 mg of polymyxin B per liter, 2 mg of amphotericin B per liter, and 6 mg of vancomycin (Fluka) per liter and incubated at 37°C under a microaerophilic atmosphere. After 2 to 3 days, 20 l was used to streak Campy blood agar plates containing brucella agar base (Difco), 10% SB, and antibiotics. Isolates were conserved in skim milk-15% glycerol-10% fetal calf serum at Ϫ80°C, after identification by gram staining and biochemical analysis For antimicrobial susceptibility assays, a suspension was adjusted to a turbidity approximating that of a McFarland no. 3 standard, spread on SB-Mueller-Hinton agar (SBMHA) plates containing 8 mg of metronidazole or tinidazole per liter, and incubated for 3 days (5, 13). Isolates were considered susceptible or resistant if similar results were obtained from three experiments. If similar results were observed in two experiments out of three, the isolates were considered susceptible or resistant but were designated as mixed populations. For the MDDM, disks containing 4, 8, 16, 32, and 64 g of metronidazole and tinidazole (prepared from pure powders; Sigma), clarithromycin (15 g; Becton Dickinson), amoxicillin (25 g), ampicillin (10 g), erythromycin (15 g), tetracycline (30 g), and ciprofloxacin (5 g) from Padtan Tab and BioMerieux were used. Bacterial suspensions were spread on SBMHA plates, disks were added, and the diameter of the zone of inhibition was measured after 3 days. Criteria for nitroimidazole susceptibility were inhibitory zones of Ն15 to 16 mm or Ն26 mm (3, 9, 12) . Quality control was ensured by using organisms from the American Type Culture Collection, including Pseudomonas aeruginosa ATCC 85327, Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 25922, and H. pylori ATCC 26695.
Of the culture-positive subjects, 98% showed gastritis, gastric ulcer, duodenitis, duodenal ulcer, and gastroduodenal ulcer; no gastric carcinoma was observed. The susceptibility pattern obtained for nitroimidazole is described in Table 1 . No difference was found in the results for disks containing increasing concentrations of antibiotic. By the SAM, 23 and 22% of isolates were susceptible to metronidazole and tinidazole. The rates of mixed populations were 7% (SAM) and 12% (MDDM) for metronidazole and 4% (SAM) and 7% (MDDM) for tinidazole. The highest agreement between the results of the SAM and those of the MDDM for nitroimidazole was observed in the case of inhibitory zones of Ն26 mm. The susceptibility patterns for other antibiotics are described in Table 2 . By SAM, the susceptibility of isolates to 8 mg of amoxicillin per liter according to European H. pylori breakpoints (9, 16) was 51%. The rates of mixed populations for amoxicillin, ampicillin, tetracycline, erythromycin, clarithromycin, and ciprofloxacin were 12, 10, 13, 7, 8, and 18%. Crossreactivity between metronidazole and tinidazole was ϳ100%. All strains that were resistant to ampicillin were also resistant to amoxicillin, and strains that were resistant to clarithromycin were also resistant to erythromycin. Of interest, of 16 isolates susceptible to metronidazole (23% by the SAM), 14 were also susceptible to other antibiotics tested. The multiresistance pattern of metronidazole-resistant isolates is described in Table 3 .
In this study, we report the susceptibility to commonly used antibiotics of pediatric H. pylori isolates from Iran. A high rate of resistance to nitroimidazole was found throughout the study; these results are similar to frequencies reported for other developing countries (14) . In Iran, metronidazole is used to treat diarrheal disease, and H. pylori strains obtained from adults are also highly resistant to metronidazole (6) . Among antibiotics examined, clarithromycin was the most effective, but 21% resistance was unexpected, since clarithromycin is not currently used in Iran. This resistance could be related to cross-reactivity between erythromycin and clarithromycin, which implies that if a strain is resistant to one macrolide it becomes resistant to all others (15) . Resistance to amoxicillin was observed in 27% of the isolates, reflecting the importance of its use in our country, especially in children. A high level of resistance to amoxicillin was also observed in Shigella spp., Salmonella spp., and Campylobacter jejuni isolates in Iran (7). Resistance to amoxicillin was also observed in Mexican children (14) . In isolates from this work, moderate resistance to tetracycline and ciprofloxacin was observed. Ciprofloxacin has been proposed for treatment of the infections noted above (7), but tetracycline is not frequently used in our pediatric medical centers; this resistance could be related to genetic acquisition of resistance due to a multidrug resistance mechanism (11) . Few studies have reported the rate of multiresistance in H. pylori isolates (4, 11, 14) . In our study, the lowest rate of multiresistance was observed for nitroimidazole plus ciprofloxacin plus tetracycline ( Table 3 ), signifying that treatment regiments could also contain ciprofloxacin as an antibiotic unrelated to the others.
In conclusion, we documented a high rate of resistance to nitroimidazole, a considerable resistance to amoxicillin, ciprofloxacin, tetracycline, erythromycin, and ampicillin, and the least resistance to clarithromycin. We confirm the need for culture and susceptibility testing to define resistance and/or multiresistance patterns of pediatric H. pylori isolates before selection of a treatment regimen. a AMX, amoxicillin; CLA, clarithromycin; TET, tetracycline; CIP, ciprofloxacin.
b Also resistant to ampicillin. c Also resistant to erythromycin.
